An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics

CompletedOBSERVATIONAL
Enrollment

328

Participants

Timeline

Start Date

October 23, 2007

Primary Completion Date

July 30, 2008

Study Completion Date

July 30, 2008

Conditions
SchizophreniaMetabolic Syndrome X
Interventions
OTHER

No intervention

Non-interventional study

Trial Locations (47)

34147

Bakirkoy Psychiatry and Neurology Hospital, Istanbul

Pfizer Investigational Site, Istanbul

01360

Adana Psychiatry and Neurology Hospital, Kurttepe

Pfizer Investigational Site, Kurttepe

Unknown

Adana Psychiatry and Neurology Hospital, Adana

Cukurova University Scool of Medicine, Adana

Pfizer Investigational Site, Adana

Ankara Diskapi Training and Research Hospital, Ankara

Ankara Numune Research Hospital, Ankara

Ankara Numune Training and Research Hospital Department of Psychiatry, Ankara

Pfizer Investigational Site, Ankara

Antakya Mustafa Kemal University School of Medicine, Antakya

Pfizer Investigational Site, Antakya

Bolu Psychiatry and Neurology Hospital, Bolu

Pfizer Investigational Site, Bolu

Pamukkale University School Of Medicine, Denizli

Pfizer Investigational Site, Denizli

Elazig Mental Illness And Diseases Hospital, Elâzığ

Pfizer Investigational Site, Elâzığ

Eskisehir Osmangazi University, Eskişehir

Pfizer Investigational Site, Eskişehir

Bakirkoy Mental Health Hospital, First Clinic of Neurosis, Istanbul

Bakirkoy Psychiatry and Neurology Hospital, Istanbul

Cerrahpasa School of Medicine, Istanbul

Erenkoy Psychology and neurology hospital, Istanbul

Istanbul University Istanbul School of Medicine, Istanbul

Marmara School of Medicine, Istanbul

Pfizer Investigational Site, Istanbul

Sisli Etfal Research and training Hospital, Istanbul

Vakif Gureba Hospital, Department of Psychiatry, Istanbul

Ege University School Of Medicine, Izmir

Pfizer Investigational Site, Izmir

Kayseri Public Hospital, Kayseri

Pfizer Investigational Site, Kayseri

Pfizer Investigational Site, Konya

Selcuk University Medical School Department of Psychiatry, Konya

Manisa Mental Illness And Diseases Hospital, Manisa

Pfizer Investigational Site, Manisa

19 may University School of Medicine, Samsun

Pfizer Investigational Site, Samsun

Samsun Mental Illness And Diseases Hospital, Samsun

Pfizer Investigational Site, Trabzon

Trabzon Numune Research Hospital, Trabzon

Pfizer Investigational Site, Trakya

Trakya University School of Medicine, Trakya

06200

Ankara Oncology Research and Training Hospital, Ankara

Pfizer Investigational Site, Ankara

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00448630 - An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics | Biotech Hunter | Biotech Hunter